Citation Impact
Citing Papers
In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter
2010 StandoutNobel
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
Intensive versus Conventional Glucose Control in Critically Ill Patients
2009 Standout
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018
Insulin and Metabolic Stress Stimulate Multisite Serine/Threonine Phosphorylation of Insulin Receptor Substrate 1 and Inhibit Tyrosine Phosphorylation
2014
The Metabolic Syndrome and Inflammation
2004
Oxidative stress and diabetic cardiovascular complications
2005
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
2018
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
2006 Standout
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials
2015
mTOR Signaling in Growth Control and Disease
2012 Standout
Inflammation and metabolic disorders
2006 StandoutNature
Metabolic and cardiovascular effects of androgen deprivation therapy
2008
Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes
2006
Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein
2007
Inhibition of Renal Glucose Reabsorption: A Novel Strategy for Achieving Glucose Control in Type 2 Diabetes Mellitus
2008
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Dynamics of fat cell turnover in humans
2008 StandoutNature
A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation
2007
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
2007
Pathophysiology of Prediabetes
2011
Optimisation of follow-up after metabolic surgery
2018
β-Cell Function in Subjects Spanning the Range from Normal Glucose Tolerance to Overt Diabetes: A New Analysis
2005
The metabolic syndrome
2010 Standout
Metabolic, anabolic, and mitogenic insulin responses: A tissue-specific perspective for insulin receptor activators
2015
Activated PKR inhibits pancreatic β-cell proliferation through sumoylation-dependent stabilization of P53
2015
The impact of antidiabetic therapies on cardiovascular disease
2005
Preservation of β-Cell Function: The Key to Diabetes Prevention
2011
Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance
2015
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2
2012
Testosterone and insulin resistance in the metabolic syndrome and T2DM in men
2013
C‐Reactive Protein (CRP)‐Lowering Agents
2006
Association Between Disease-Modifying Antirheumatic Drugs and Diabetes Risk in Patients With Rheumatoid Arthritis and Psoriasis
2011
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study
2009
Management of Hyperglycemia in the Hospital Setting
2006
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
2013
Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance—the Chennai Urban Rural Epidemiology Study (CURES)
2006
Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD
2007
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
2020
Molecular insights into insulin action and secretion
2002
RBP4: a controversial adipokine
2011
The metabolic syndrome
2005 Standout
Non-alcoholic fatty liver disease
2021 Standout
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study
2012
Insulin action and resistance in obesity and type 2 diabetes
2017
Dysfunctional fat cells, lipotoxicity and type 2 diabetes
2004
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
2017 Standout
Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels
2017
Gut metagenome in European women with normal, impaired and diabetic glucose control
2013 StandoutNature
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Adiponectin in relation to insulin sensitivity and insulin secretion in the development of type 2 diabetes: a prospective study in 64-year-old women
2010
Thiazolidinediones improve β-cell function in type 2 diabetic patients
2006
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
2005
Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to Type 2 diabetes
2004
Origin and physiological roles of inflammation
2008 StandoutNature
A Subpopulation of Macrophages Infiltrates Hypertrophic Adipose Tissue and Is Activated by Free Fatty Acids via Toll-like Receptors 2 and 4 and JNK-dependent Pathways
2007
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
The metabolic syndrome—a new worldwide definition
2005 Standout
Contributions of -Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose
2006
Dapagliflozin: A Review of Its Use in Patients with Type 2 Diabetes
2014
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
2002 Standout
Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes
2008
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
The Role of Adipose Tissue and Lipotoxicity in the Pathogenesis of Type 2 Diabetes
2010
Long-term effects of high-fat or high-carbohydrate diets on glucose tolerance in mice with heterozygous carnitine palmitoyltransferase-1a deficiency
2011
Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial
2009
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle
2007
LRRC8 Proteins Form Volume-Regulated Anion Channels that Sense Ionic Strength
2016 StandoutNobel
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
2017
Endothelial Progenitor Cells and Vascular Biology in Diabetes Mellitus: Current Knowledge and Future Perspectives
2005
Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol
2018
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Predictors of and Longitudinal Changes in Insulin Sensitivity and Secretion Preceding Onset of Type 2 Diabetes
2005
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Physiological and Molecular Determinants of Insulin Action in the Baboon
2008
Factor for Adipocyte Differentiation 158 Gene Disruption Prevents the Body Weight Gain and Insulin Resistance Induced by a High-Fat Diet
2011
Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add‐on therapy in subjects with new‐onset diabetes. Results from the E fficacy and D urability of I nitial C ombination T herapy for T ype 2 D iabetes ( EDICT ): a randomized trial
2014
Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)
2007
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
2006
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
2016
Distinct β-Cell Defects in Impaired Fasting Glucose and Impaired Glucose Tolerance
2012
Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach
2004
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Exosomes as new players in metabolic organ cross‐talk
2017
Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study
2017
Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited
2004
Free Fatty Acids Are Independently Associated with All-Cause and Cardiovascular Mortality in Subjects with Coronary Artery Disease
2006
A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain
2010
The relative contributions of insulin resistance and beta cell failure to the transition from normal to impaired glucose tolerance varies in different ethnic groups
2007
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Heritability of Insulin Secretion, Peripheral and Hepatic Insulin Action, and Intracellular Glucose Partitioning in Young and Old Danish Twins
2005
Role of PKCδ in Insulin Sensitivity and Skeletal Muscle Metabolism
2015
Comparison between SGLT2 inhibitors and DPP4 inhibitors added to insulin therapy in type 2 diabetes: a systematic review with indirect comparison meta‐analysis
2016
Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease
2016
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
2015
Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences
2015
Alterations in Glutathione Redox Metabolism, Oxidative Stress, and Mitochondrial Function in the Left Ventricle of Elderly Zucker Diabetic Fatty Rat Heart
2012
Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
2017
Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young Adults
2008
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism
2008
Skeletal muscle insulin resistance: role of mitochondria and other ROS sources
2017
New Drugs for the Treatment of Diabetes Mellitus
2008
Inflamed Adipose Tissue
2007
Inflammatory Mechanisms in Obesity
2011 Standout
Regulation of metabolism by the innate immune system
2015
The Metabolic Syndrome
2008 Standout
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet
2011 StandoutNobel
Understanding the Physiology of FGF21
2015
Impact of Differences in Fasting Glucose and Glucose Tolerance on the Hyperbolic Relationship Between Insulin Sensitivity and Insulin Responses
2006
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Impaired Fasting Glucose and Impaired Glucose Tolerance
2007
Comparison of Pioglitazone and Gliclazide in Sustaining Glycemic Control Over 2 Years in Patients With Type 2 Diabetes
2005
Cellular Mechanisms by Which FGF21 Improves Insulin Sensitivity in Male Mice
2013
The regulation of glucose metabolism: implications and considerations for the assessment of glucose homeostasis in rodents
2014
A truncation mutation in TBC1D4 in a family with acanthosis nigricans and postprandial hyperinsulinemia
2009
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
2018
Full Accounting of Diabetes and Pre-Diabetes in the U.S. Population in 1988–1994 and 2005–2006
2008
Retinol-Binding Protein 4 Inhibits Insulin Signaling in Adipocytes by Inducing Proinflammatory Cytokines in Macrophages through a c-Jun N-Terminal Kinase- and Toll-Like Receptor 4-Dependent and Retinol-Independent Mechanism
2012
Works of Devjit Tripathy being referenced
Actos Now for the prevention of diabetes (ACT NOW) study
2009
Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband
2003
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
2011
Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance
2008
Defects in Insulin Secretion and Action in the Pathogenesis of Type 2 Diabetes Mellitus
2010
Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in Type 2 diabetes
2004
Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-κB in mononuclear cells
2004
Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW
2016
Evidence for a Potent Antiinflammatory Effect of Rosiglitazone
2004
A Novel Insulin Resistance Index to Monitor Changes in Insulin Sensitivity and Glucose Tolerance: the ACT NOW Study
2015
Insulin Resistance as a Proinflammatory State: Mechanisms, Mediators, and Therapeutic Interventions
2003
Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans
2009
Increase in intranuclear nuclear factor κB and decrease in inhibitor κB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect
2004
Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo
2008
Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study
2016
Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.
2000
Contribution of Insulin-Stimulated Glucose Uptake and Basal Hepatic Insulin Sensitivity to Surrogate Measures of Insulin Sensitivity
2004
Angiotensin II Receptor Blocker Valsartan Suppresses Reactive Oxygen Species Generation in Leukocytes, Nuclear Factor-κB, in Mononuclear Cells of Normal Subjects: Evidence of an Antiinflammatory Action
2003
Contributions of β-Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose
2006
Importance of Obtaining Independent Measures of Insulin Secretion and Insulin Sensitivity During the Same Test
2003
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
2009 Standout
Free Fatty Acid-Induced Insulin Resistance in the Obese Is Not Prevented by Rosiglitazone Treatment
2005
Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors
2012
Effect of Short-Term Free Fatty Acids Elevation on Mitochondrial Function in Skeletal Muscle of Healthy Individuals
2009
Anti-Inflammatory and Profibrinolytic Effect of Insulin in Acute ST-Segment–Elevation Myocardial Infarction
2004
The Disposition Index Does Not Reflect β-Cell Function in IGT Subjects Treated With Pioglitazone
2014
Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
2014
Prediction of Diabetes Based on Baseline Metabolic Characteristics in Individuals at High Risk
2013
Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study
2009
Chronic Reduction of Plasma Free Fatty Acid Improves Mitochondrial Function and Whole-Body Insulin Sensitivity in Obese and Type 2 Diabetic Individuals
2013
Insulin Secretion and Action in Subjects With Impaired Fasting Glucose and Impaired Glucose Tolerance
2006
Relationship Between Testosterone Levels, Insulin Sensitivity, and Mitochondrial Function in Men
2005
Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance
2009
Elevation of Free Fatty Acids Induces Inflammation and Impairs Vascular Reactivity in Healthy Subjects
2003